Opioids and non-opioids analgesics such as such as non-steroidal anti-inflammatory drugs (NSAIDs), ketamine and nefopam are the mainstays for achieving postoperative analgesia, but contraindications and safety concerns limit their widespread use.
Supplementation with
dexmedetomidine decreases consumption of morphine, improves analgesic effects
and subjective sleep quality without an increase in adverse effects in elderly
patients after open abdominal surgery.
Opioids and non-opioids analgesics such as such as non-steroidal anti-inflammatory drugs (NSAIDs), ketamine and nefopam are the mainstays for achieving postoperative analgesia, but contraindications and safety concerns limit their widespread use. The use of these drugs is limited in elderly who have a higher incidence of cerebral, cardiovascular and postoperative neuropsychological events. Dexmedetomidine, a highly selective α-2 receptor agonist, is used as an alternative and shows some advantages in the management of pain. Studies have shown that the use of dexmedetomidine for acute pain after surgery can decrease the opioid consumption and improve analgesic effects, but the interpretation of results needs utmost care. Firstly, data were collected from studies that enrolled younger patients rather than elder ones. Also, the safety outcomes were not studied in detail in the majority of patients. It was also reported that infusion of a high dose of dexmedetomidine produces sedation and lowers heart rate and systolic blood pressure. The sedative dose of dexmedetomidine also inhibits the ventilatory response to hypercapnia and hypoxia in healthy volunteers. Therefore, safety remains a significant concern for the use of dexmedetomidine for achieving analgesia.
Rationale behind research:
The previous studies have indicated that the infusion of low
dose dexmedetomidine improves sleep quality in elderly patients in the
intensive care unit (ICU) after surgery, but evidence for explaining this
aspect are still lacking. So, this study was organised to evaluate the effects
of dexmedetomidine in improving sleep parameters in postoperative
patients.
Objective:
The
present study intended to determine the effects of dexmedetomidine in
combination with morphine on sleep quality, analgesia and safety outcomes in
elderly patients after open abdominal surgery.
Study outcomes:
Time Points: 4, 12,
24, 48, and 72 hours
Outcomes:
Baseline: There were no significant differences observed at
baseline
Study outcomes:
Fig 2. Cumulative consumption of morphine at different time points after
surgery
The present study indicated that the combined use of
dexmedetomidine and morphine for PCIA could reduce morphine consumption in
elderly patients after open abdominal surgery.
Combination of dexmedetomidine and morphine significantly improves
analgesic effects & sleep quality and also decreases the occurrence of
PONV, without increasing the risk of adverse effects. The dose or infusion rate
of dexmedetomidine also varies widely when used for postoperative analgesia. In
the present study, the rate of dexmedetomidine infusion was set at 2μg/h (i.e.,
approx. 0.02–0.04 μg/kg/h according to the body weight of enrolled
patients). A lower background infusion
rate was favored due to its effectiveness in reducing opioid consumption, and
its expected duration of dexmedetomidine infusion was 72 hours in the abdominal
surgery. Infusion of low-dose dexmedetomidine (at a rate of 0.1μg/ kg/h) during
the night also influence sleep structure (by decreasing stage N1 sleep,
increasing stage N2 sleep and sleep efficiency) and subjective sleep quality.
Infusion of dexmedetomidine improved sleep quality postoperatively during the
first night of surgery. The results were
comparable with the results of the previous studies. Polysomnography and its effects on sleep
efficiency and architecture were not determined in the present study.
Dexmedetomidine administered by patient-controlled
intravenous analgesia can also aid in the improvement of postoperative outcome.
The incidence of complications was lower in the DEX group after surgery. The results of the study did not show any
differences in the occurrence of side effects. There is a need for further
trials with large sample size, to elucidate the results in the geriatric
patients.
The results of the study confirmed that dexmedetomidine in
combination with morphine for PCIA reduces consumption of morphine, improves
analgesic effects and subjective sleep quality without increasing adverse
events and it might be helpful for the clinicians in the management of
postoperative pain after open abdominal surgery.
PLoS ONE 13(8): e0202008
Dexmedetomidine in combination with morphine improves postoperative analgesia and sleep quality in elderly patients after open abdominal surgery: A pilot randomized control trial
Huai-Jin Li et al.
Comments (0)